Illumina’s constellation tech a star in Genedx pilot
Genedx LLC partnered with Illumina Inc. to test whether Illumina’s constellation map read technology could shed light on…
Rising antibiotic resistance is putting routine infections back in the danger zone
A new WHO analysis reveals accelerating resistance in critical pathogens and widening global inequities, urging countries to strengthen…
Asia-Pacific steps up in longevity medicine
Manjit Sareen reflects on the first Asia-Pacific Longevity Medicine International Summit and the launch of a global directory…
Sei and WaiveDx partner to build a blockchain healthspan economy
Collaboration aims to connect AI diagnostics, personalized health and blockchain to create an incentive-based longevity ecosystem. A new…
Baylor Genetics to Showcase Clinical and Diagnostic Utility
HOUSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) — Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic…
Taste-based flu test that detects infection within minutes
A new study reveals that a simple taste could one day tell you if you have the flu,…
Project plots a quantum leap to bridge healthcare gap
The University of Western Australia is part of an international consortium that hopes to harness quantum computing technology…
Cell imaging technique could transform diagnostics | CoCID Project | Results in Brief | H2020 | CORDIS
Capturing exactly what happens to a cell when it is invaded by a virus could help scientists to…
AI heart scan targets risk before plaque
Biograph partners with Caristo Diagnostics to bring CaRi-Heart to the US and open preventive pathways in cardiology. Cardiovascular…
Genomenon and Compass Bioinformatics to transform genomic diagnostics in US and Japan
Genomenon and Compass Bioinformatics to transform genomic diagnostics in US and Japan September 24, 2025 | Wednesday |…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
Blood-based biomarkers reveal barriers to diversity in Alzheimer’s disease trials
Some of the populations with the highest risk for Alzheimer’s disease remain greatly underrepresented in clinical trials-and a…